Towa Pharmaceutical Co. Ltd’s. purchase of the Pensa Investments generics business from Spain’s Esteve exceeded expectations in the Japanese firm’s financial first quarter ended 30 June, overachieving for both net sales and operating profit in the wake of the COVID-19 pandemic.
Net sales of ¥9.96bn ($93.9m) for the international business were “above plan due to increased demand for pharmaceuticals as a...






